The presence of cardiogenic shock (CS) in a setting of aortic stenosis ranges from 1% to 4%. The prognosis for this scenario is ominous due to subendocardial ischemia, which presents as a decrease in ventricular preload and an increase in afterload. Aortic valvuloplasty has been used in this context, but, unfortunately, it has been associated<a href="https://solaci.org/en/2023/11/09/is-tavr-beneficial-in-cardiogenic-shock/" title="Read more" >...</a>
The second group of Women Interventionists sponsored by SOLACI has started the training on structural disease as part of our scholarship program at the Instituto Cardiovascular de Rosario (ICR). The program will take place over the course of this week in different centers across Argentina. During the session, the grant holders were able to attend<a href="https://solaci.org/en/2023/09/27/mil-train-more-mil-the-second-week-of-training-has-started/" title="Read more" >...</a>
Moderate aortic stenosis (MAS) encompasses a broader spectrum than severe aortic stenosis. However, its progression has not yet been fully elucidated. While there are reports suggesting that this condition is not as benign as initially believed, there is a need to consider early interventions in certain instances. Researchers conducted an analysis from January 2016 to<a href="https://solaci.org/en/2023/08/17/moderate-aortic-stenosis-we-should-start-assessing-it-more-thoroughly/" title="Read more" >...</a>
The clinical importance of severe tricuspid regurgitation (TR) has been underestimated for many years now. However, studies and registries have shown that, when left untreated, this pathology significantly increases morbidity and mortality. Patients in need of treatment are often older individuals with higher surgical risk due to the prevalence of this condition. Contemporary data has<a href="https://solaci.org/en/2023/08/14/bright-impact-and-safety-of-the-triclip-device-in-a-real-world-cohort/" title="Read more" >...</a>
The third day of the Congress started at the Copacabana Arena with the International Live Case held at Nanjing First Hospital, Nanjing, China, which showcased a successful and illustrative step-by-step Transcatheter Coronary Intervention (TCI) angioplasty with circulatory support and optimized results using Intravascular Ultrasound (IVUS) applicability. Following that, Dr. Fei Ye presented Intravascular Imaging and<a href="https://solaci.org/en/2023/08/05/solaci-sbhci-2023-scientific-coverage-day-3/" title="Read more" >...</a>
Today, the SOLACI SBHCI 2023 Congress, the largest interventional cardiology event in Latin America, organized by the Latin American Society of Interventional Cardiology (SOLACI) and the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), began in Rio de Janeiro. The event is taking place between August 2nd August 4th at the Windsor Convention Center &<a href="https://solaci.org/en/2023/08/03/congress-solaci-sbhci-2023-day-1-summary/" title="Read more" >...</a>
TAVR has been shown beneficial in patients across the risk spectrum. The PARTNER 2 SAPIEN 3 (P2S3i) study on intermediate risk patients was the first to show TAVR superiority vs SAVR when using the transfemoral approach. SAVR durability has been shown in different analysis but, except for a few reports, TAVR durability at long term<a href="https://solaci.org/en/2023/07/11/tavr-durability-at-5-years-in-intermediate-risk-patients/" title="Read more" >...</a>
Percutaneous treatment of chronic total occlusions has increase, and has become a a more habitual therapeutic challenge. However, there is limited information on distal vessel quality and its association with outcomes and techniques. This variable appears to be excluded form CTO scores, except for the RECHARGE (REgistry of CrossBoss and Hybrid procedures in FrAnce, the<a href="https://solaci.org/en/2023/07/06/relationship-between-distal-vessel-quality-and-outcomes-in-the-treatment-of-chronic-total-occlusions/" title="Read more" >...</a>
Cardiogenic shock (CS) in a setting of aortic stenosis is associated with high mortality rates. In consequence, surgery is generally not a possibility for this patient group, and they usually undergo aortic valvuloplasty, resulting in a mortality rate of 33%-50% at 30 days, 70% at one year, and 90% at two years. While transcatheter aortic<a href="https://solaci.org/en/2023/07/04/aortic-stenosis-and-cardiogenic-shock-is-tavr-an-option/" title="Read more" >...</a>
The natural history of tricuspid regurgitation is associated to hospitalization for cardiac failure and mortality. This is why the AHA/ACC guidelines recommend surgery when the tricuspid fails during left valve surgical repair, because its slow progression is associated with high mortality (35%). Many of these patients are high risk and percutaneous intervention has surged as<a href="https://solaci.org/en/2023/05/12/latest-developments-in-tricuspid-regurgitation/" title="Read more" >...</a>